Clinical Trial Detail

NCT ID NCT02833701
Title Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Nebraska
Indications

malignant glioma

Therapies

Bevacizumab

Age Groups: senior adult

No variant requirements are available.